Inside ASTMH

In February, ASTMH became a self-managed Society. We are using this moment to introduce the Society's staff, beginning with CEO Karen A. Goraleski.

Read the February 2019 Washington, DC update here

CDC has announced that it will make intravenous artesunate available for the treatment of severe malaria once quinidine is no longer available beginning April 1, 2019. ASTMH President Chandy C. John called it "a big advance for malaria treatment in the United States."

Last fall, President Chandy C. John, MD, MS, FASTMH, asked members to answer a single question: "What one thing should ASTMH do to become a better and more effective Society?" See how members responded.
 

Read the January 2019 Washington, DC update here

With the January 2019 issue, the American Journal of Tropical Medicine and Hygiene (AJTMH) celebrates its 100th volume.

What's on the Horizon for Tropical Infectious Disease? ASTMH Leaders Offer Their Insight

Read the December 2018 Washington, DC update here